Formula-Y
Formula-Y is at the forefront of antibody development, integrating artificial intelligence and synthetic biology to revolutionize the design and development process. By replacing traditional methods like hybridoma technology and phage display with proprietary, faster, and more efficient techniques, Formula-Y aims to streamline drug discovery. Their platform includes target identification, epitope prediction, antibody discovery, in-silico validation, synthesis, and humanization of antibodies, making it a game-changer in the field. With a focus on innovation and efficiency, Formula-Y is positioned to lead the market in therapeutic antibody development, collaborating with drug development partners to create targeted solutions that save time and resources.
Formula-Y
Formula-Y is at the forefront of antibody development, integrating artificial intelligence and synthetic biology to revolutionize the design and development process. By replacing traditional methods like hybridoma technology and phage display with proprietary, faster, and more efficient techniques, Formula-Y aims to streamline drug discovery. Their platform includes target identification, epitope prediction, antibody discovery, in-silico validation, synthesis, and humanization of antibodies, making it a game-changer in the field. With a focus on innovation and efficiency, Formula-Y is positioned to lead the market in therapeutic antibody development, collaborating with drug development partners to create targeted solutions that save time and resources.